MA16.06 Real-world Survival with CRT+durvalumab for Unresectable, Stage III NSCLC in Canada: the RELEVANCE Study

Authors:
  • PWP. Wheatley-Price
    P. Wheatley-Price
  • VNV. Navani
    V. Navani
  • APA. Pabani
    A. Pabani
  • BRB. Routy
    B. Routy
  • SSS. Snow
    S. Snow
  • MDM.-H. Denault
    M.-H. Denault
  • YKY. Kim
    Y. Kim
  • ISI. Syed
    I. Syed
  • NDN. Devost
    N. Devost
  • DHD. Hui
    D. Hui
  • PAP. Arora
    P. Arora
  • RVR. Velummailum
    R. Velummailum

Abstract
No abstract available